COMMUNIQUÉS West-GlobeNewswire

Annual General and Special Meeting of Shareholders to be held May 7, 2026
21/04/2026
TORONTO, April 21, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and [...]
Corvus Pharmaceuticals to Host Investor and Analyst Meeting on May 14, 2026 to Highlight Soquelitinib Data Being Presented at the Society for Investigative Dermatology (SID) Annual Meeting
21/04/2026
Two oral presentations including late-breaker at SID Data will cover Phase 1 clinical trial of soquelitinib for atopic dermatitis, including new immunologic and biomarker data supporting drug-free remissions Investor [...]
Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab™ Platform
21/04/2026
VANCOUVER, British Columbia, April 21, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the " Company " or “ Avricore ”) announces HealthTab™ has now screened more than 3,500 patients in community pharmacies [...]
Medicenna Presents Positive Data Demonstrating Superior Safety and Efficacy Potential of its First-in-Class anti-PD-1 x IL-2 Bifunctional Superkine MDNA113 at AACR 2026
21/04/2026
New in vivo data demonstrate exceptional selectivity, localization and potency of MDNA113 in the tumor and tumor microenvironment while enhancing the systemic tolerability profile Head-to-head non-human primate [...]
Plus Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
21/04/2026
HOUSTON, April 21, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous [...]
Nobel-Potential Discovery from VectorBuilder Scientists Reveals Fundamental Mechanisms of Development
21/04/2026
CHICAGO, April 21, 2026 (GLOBE NEWSWIRE) -- One of the most fundamental questions in biology is how a single fertilized egg produces the diverse cell types making up the body – from neurons and skin to muscle and blood [...]
AAVantgarde announces completion of recruitment in STELLA natural history study
21/04/2026
MILAN, April 21, 2026 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company pioneering next-generation gene therapies for inherited retinal diseases (IRDs) has today announced the [...]
Dark Horse Consulting Group’s Acquisition of CJ PARTNERS Provides Regional Expansion
21/04/2026
WALNUT CREEK, Calif. and TOKYO, April 21, 2026 (GLOBE NEWSWIRE) -- Dark Horse Consulting Group (“DHCG” or “the Group”) today announced the acquisition of CJ PARTNERS (“CJP”), a distinguished consulting and advisory firm [...]
Xeltis receives CE mark for aXess™, its aXess hemodialysis conduit™, as it moves to commercialization
21/04/2026
CE mark awarded for aXess™ at record speed, underpinned by strong EU pivotal trial data Xeltis advances ahead of schedule to commercialization aXess™ reduces the need for vascular access interventions enabling more [...]
Groundbreaking approaches such as cell therapies on the horizon for transformation of neural hearing loss, Rinri Therapeutics’ review1 shows
21/04/2026
Elevating the importance of neural health via better diagnosis and treatment is crucial for restoration of natural hearing, JARO review concludes Sheffield, UK, April 21, 2026 (GLOBE NEWSWIRE) -- The role of neural [...]
Amphista Therapeutics presents the discovery, characterisation and chemical structure of AMX-883, an orally bioavailable, highly potent and selective DCAF16 degrader of BRD9 at AACR 2026
21/04/2026
First public disclosure of the chemical structure of AMX-883, an orally bioavailable, highly potent and selective DCAF16-dependent Targeted Glue™ degrader of BRD9 AMX-883 is the Company’s lead asset entering a Phase I [...]
Transactions in connection with share buy-back program
21/04/2026
Company announcement no. 11 - 26 21 April 2026 Transactions in connection with share buy-back program On 4 March 2026 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company [...]
Grady Manual Therapy Ltd Champions "Exercise is Medicine" to Deliver Professional Sports Health Care to Everyday Athletes in Hong Kong
21/04/2026
HONG KONG, April 21, 2026 (GLOBE NEWSWIRE) -- Grady Manual Therapy Ltd today highlighted its ongoing mission to provide professional-grade sports health care and emergency field support to non-occupational athletes. [...]
FDA accepts application for Roche’s Gazyva/Gazyvaro for the treatment of the most common form of lupus
21/04/2026
Filing acceptance based on phase III ALLEGORY data for Gazyva/Gazyvaro showing a significant reduction in disease activity compared with placebo in people with systemic lupus erythematosus (SLE) If approved, Gazyva/ [...]
Rapid Nutrition Establishes Flagship Platform to Strengthen Multi-Channel Strategy in Australia
21/04/2026
Expected to generate additional revenue through product sales and supplier-funded activation programmes LONDON, April 20, 2026 (GLOBE NEWSWIRE) -- Rapid Nutrition PLC (Euronext Growth: ALRPD ), a global HealthTech [...]
Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Non-Human Primate Chronic Cough Model
21/04/2026
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 21, 2026 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel [...]
TRT UK - What Is TRT and Who Should Take a TRT Test? A Complete UK Guide
21/04/2026
Rising Interest in TRT UK: What Current Medical Guidance Says About Symptoms, Testing, and Access to Treatment Hampshire, England, April 21, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This content is provided for [...]
SnoreRX Anti-Snoring Mouthpiece Claims Evaluated: Doctor-Recommended Adjustable Mouthguard for Safer Airway Breathing Overnight
21/04/2026
SnoreRX examines its FDA-cleared mandibular advancement mouthpiece design, 1-millimeter adjustable calibration, boil-and-bite custom fitting process, 30-day guarantee terms, pricing structure, and what consumers should [...]
Enjoin Launches Technology-First Rebrand For Scalable Revenue Integrity
21/04/2026
Enjoin, a clinically intelligent revenue optimization platform for health systems, announced a refreshed brand identity reflecting continued investment in workflow-driven technology, advanced analytics, and clinical [...]

Pages